Director, Molecular Regulatory Affairs North America
DiaSorin | |
United States, Texas, Austin | |
Aug 05, 2026 | |
|
Obsessed by Science. Entrepreneurial by Nature. United by Purpose. Diasorin is a global leader in immunodiagnostic and molecular diagnostic solutions, advancing science to improve patient outcomes worldwide. For more than 50 years, we have combined scientific rigor with an entrepreneurial mindset, operating with a strong commitment to innovation, accountability, and results to deliver trusted diagnostic solutions. As the Diagnostics Specialist, Diasorin continuously invests in research, technology, and people. Guided by our values of operational excellence, customer focus, and teamwork, we empower teams to think boldly, act decisively, and transform ideas into meaningful impact across one of the industry's broadest specialty diagnostic portfolios. When you join Diasorin, you are not just filling a role. You are helping build what comes next. Why Join Diasorin
Director Molecular Regulatory Affairs, North America Company Overview: Diasorin is a global leader in diagnostic solutions, providing innovative products and services to healthcare providers across the world. Our Immuno and Molecular Diagnostics teams focus on delivering state-of-the-art diagnostic technologies and solutions that improve patient outcomes. As we continue to expand our presence in North America, we are seeking a Director of Molecular Regulatory Affairs, North America to support the Molecular RA team and RA VP NA in identified the regulatory strategy, ensuring our products meet all regulatory requirements in the region while supporting our ambitious growth in the Immuno and Molecular Diagnostics markets. Position Overview: The Director of Molecular Regulatory Affairs, North America, will be responsible for supporting all regulatory functions and activities related to Molecular Diagnostics products across North America. This leadership role will ensure full support in identifying regulatory strategies to be aligned with company goals and the evolving regulatory environment in the healthcare industry. The Director Molecular RA, NA will also collaborate with key cross-functional teams including R&D, Legal, Marketing, Clinical Affairs, and Operations to assure RA Compliance in submission process for North American market, including the United States and Canada. Key Responsibilities:
Key Qualifications:
Diasorin is committed to building a workplace where people feel empowered to contribute ideas, take ownership, and grow their careers. We believe diverse perspectives strengthen innovation and help us deliver meaningful impact for patients and customers worldwide. Diasorin is an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, protected veteran status, or any other characteristic protected by applicable law. This posting and recruitment process are subject to applicable local laws and regulations in the country where the position is located. Additional employment disclosures, candidate rights, and employment conditions may apply based on local jurisdiction. Individuals hired will be required to verify identity and eligibility to work and may be subject to a background check and drug screening where permitted by law. Diasorin is committed to providing reasonable accommodations for qualified individuals with disabilities during the application process. If assistance is required, please contact hr@diasorin.com. Recruitment Fraud Notice Diasorin never requests payment, financial information, or personal banking details from candidates at any stage of the recruitment process. Official communications from Diasorin recruiters will only come from a verified @diasorin.com email address. If you have questions about the legitimacy of a recruitment communication, please contact hr@diasorin.com for verification. Unauthorized third-party recruiting agencies may not submit candidates for this position without prior written authorization from the Diasorin Human Resources Department. | |
Aug 05, 2026